Menarini News / 5

By marking #BPDCNday, Menarini Group is giving a rare and aggressive blood cancer nowhere to hide

Together, we make a difference Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a rare hematologic malignancy that often manifests with skin lesions. Although BPDCN is mostly diagnosed in elderly patients, it may occur at any age,1,2 with men three times more likely to be affected than women. There are roughly 700 cases in the United []

trending_flat Read more

Menarini launches “Infection in Focus” portal to fight antimicrobial resistance

Ever since penicillin was discovered in 1928, antibiotics, medicines used to prevent and treat bacterial infections, have made an enormous contribution to global health and diseases that were once deemed to be fatal have been successfully treated for decades. The development of antibiotics is recognised as one of the greatest advances in therapeutic medicine. Antibiotics []

trending_flat Read more